In November, the KOSDAQ pharmaceuticals components also suffered a slump.According to the Korea Exchange, 94 out of 107 components of the pharmaceuticals index fell last month, and 74 stocks recorded double-digit declines.In particular, the stock price of Scm Life plunged 31.8%, while that of Nibec,

Pharmaceutical stocks are falling endlessly.According to the Korea Exchange, 37 out of the 45 pharmaceutical stocks in the KOSPI market fell in November, and 21 of them recorded double-digit declines.On the other hand, only 8 stocks rose during the same period, while only 3 stocks made double-digit

Sales of vaccines as well as antiviral drugs and antibody treatments are increasing significantly due to the global spread of COVID-19.Since vaccinations began in the U.S. in the fourth quarter of last year, treatments sales have decreased significantly, but their demand has increased dramatically i

Samjin Pharmaceutical in the top 50 among the traditional pharmaceutical companies… 12 companies recorded double-digit operating marginsOf the 662 corporations (excluding the financial sector) whose closing account is at the end of December in the KOSPI market, nine companies in the pharmaceutical s

In the third quarter, 10 out of 662 KOSPI-listed (excluding finance industry) pharmaceutical firms whose closing account is at the end of December ranked in the top 200 in earnings ranking (based on individual financial statements).None of the companies placed in the top 100 in sales in the pharmace

The growth rate of exports of diagnostic reagents turned negative.This is because exports, which had increased sharply for a year since the COVID-19 pandemic, have decreased significantly since April as the base effect has been added to vaccinations.Exports of diagnostic reagents (HS3822) in October

In the third quarter, the growth of major global big pharma’s oncology business unit was somewhat sluggish compared to the first half.Among them, MSD achieved sales exceeding KRW 5 trillion with Keytruda alone, overwhelming the total sales of other companies’ oncology business units. Its 9-month cum

In the third quarter, a total of 121 drug-related data were listed on the Korean version of Orange Book. In 2019, the Ministry of Food and Drug Safety established the K-Orange Book with the aim of strengthening access to generic drug-related information.K-Orange Book provides data such as ▲generics

In the third quarter, the cost of sales burden for top pharmaceutical companies decreased slightly.The average cost of goods sold (COGS) ratio of six top pharmaceutical companies, including GC Pharma, Yuhan Corporation, Chong Kun Dang Pharmaceutical, Hanmi Pharmaceutical, Daewoong Pharmaceutical, an

In October, there was a clear difference in pharmaceutical stocks by investors.According to the Korea Exchange, institutional investors’ net sales amounted to KRW 390.7 billion in October for 45 compositions of the pharmaceutical index.Samsung Biologics was the only company that institutions net bou

The pharmaceutical stocks have been floundering around.According to the Korea Exchange, the KOSPI pharmaceuticals index on 29 October was 17,107.05, a drop of 10.5% from 18,897,89 at the end of September (30th).Among the 45 stocks, 38 pharmaceutical stocks fell in a month.In particular, the three ma

Over the past year, the number of non-regular works in the human health and social work activities industry has increased significantly.According to the “August 2021 Additional Survey by Type of Employment of the Survey on the Economically Active Population” compiled by Statistics Korea on the 26th,

Jardiance generics (Ingredient: Empagliflozin, Boehringer Ingelheim) accounted for nearly 10% of drugs approved by the Ministry of Food and Drug Safety (MFDS) in the third quarter.A total of 352 drugs (excluding herbal medicines) were approved, according to the MFDS.Two-thirds (235) of them were pre

Monthly exports of pharmaceutical products have returned to the $700 million mark in half a year, but the deficit is snowballing as imports soar.According to the report from the Korea International Trade Association (KITA), monthly exports of medicinal and pharmaceutical products (SITC54) in Septemb

Exports of diagnostic regents have returned to the $119 million mark. However, the decrease was even greater compared to the same period last year.According to the data from the Korea Customs Service, exports of diagnostic reagents (HS3822) plunged 31.6% YoY to $195.75 million in September.Exports o

In the third quarter, the number of the patent announcement by pharmaceutical and bio companies decreased significantly.According to Newsmp’s tally of patent disclosures in the third quarter through the DART (Disclaimer of Liability & Use/Accuracy of Information), patent disclosures in all industrie

The National Pension Service of Korea (NPS) has built a 5% stake in SK Bioscience and ST Pharm in the third quarter.On the 6th, the NPS announced the ‘5% rule’ (as of September 30) on 7 pharmaceutical and bio companies, including SK Bioscience, ST Pharm, Pharma Research Products, Pharma Research Pro

While pharmaceutical stocks had their worst time in the third quarter, they also struggled with the market capitalization rankings.Newsmp collected data of Q3 market cap rankings of 59 pharmaceutical-related stocks (including preferred stocks) out of 938 listed stocks in the securities market (as of

The KOSPI pharmaceutical stocks, which had been burning for August and relieving the slump of the first half, cooled down in the cold wind of fall.The pharmaceuticals index, which started at 18,000 in August and exceeded 21,000 points, began at 21,000 in September and eventually returned to 18,000 p

Korea’s exports of pharmaceutical products to Germany have increased significantly, exceeding $1.5 billion for 8 months.On the other hand, as imports from Belgium rose sharply, Korea became the second-largest trade deficit country in pharmaceutical products after the United States.According to the d